Dr. Mohamed M. Zayed, MD
Claim this profileMore about Mohamed M. Zayed, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Mohamed M. Zayed, MD has experience with
- AAA Group (Aim 3A)
- AAA Group (Aim 3B-Reproducibility)
- Ex Vivo Human AAA Specimens
- Non-AAA Group
Breakdown of trials Mohamed M. Zayed, MD has run
Abdominal Aortic Aneurysm
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mohamed M. Zayed, MD specialize in?
Mohamed M. Zayed, MD focuses on Healthy aorta and Abdominal Aortic Aneurysm. In particular, much of their work with Healthy aorta has involved treating patients, or patients who are undergoing treatment.
Is Mohamed M. Zayed, MD currently recruiting for clinical trials?
No, Mohamed M. Zayed, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Mohamed M. Zayed, MD has studied deeply?
Yes, Mohamed M. Zayed, MD has studied treatments such as AAA Group (Aim 3A), AAA Group (Aim 3B-Reproducibility), Ex Vivo Human AAA Specimens.
What is the best way to schedule an appointment with Mohamed M. Zayed, MD?
Apply for one of the trials that Mohamed M. Zayed, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.